These differences may or may not be significant enough to alter the expected efficacy of the intervention, but having a cohort of patients enrolled in trials that is at least somewhat representative of the real-world population ensures that results from these studies are generalizable to the overall population.
← all excerpts
Disparities in Clinical Trial Enrollment- Focus on CAR-T and Bispecific Antibody Therapies.
1
—
—